Skip to content

Development of the new prognostic markers for breast cancer patients based on immunoresponse monitoring

Development of the new prognostic markers for breast cancer patients based on immunoresponse monitoring - New prognostic markers for breast cancer patients based on immunoresponse monitoring

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000029036
Enrollment
300
Registered
2017-09-08
Start date
2015-12-21
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast cancer

Interventions

None listed

Sponsors

Juntendo University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Breast cancer patients who are going to undergo surgery at our department

Exclusion criteria

Exclusion criteria: Patients who didn't agree to participate in this study

Design outcomes

Primary

MeasureTime frame
Subset of lymphocytes is investigated using flow cytometry and the relationship with patient outcome will be analysed.

Countries

Japan

Contacts

Public ContactYoshiya Horimoto

Juntendo University School of Medicine Department of Breast Oncology

yoshiyahorimoto@hotmail.com03-3813-3111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026